Open access
142
Views
7
CrossRef citations to date
0
Altmetric
Original Research
Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan
Ataru Igarashi1 Department of Drug Policy and Management, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan
, Manabu Akazawa2 Department of Public Health and Epidemiology, Meiji Pharmaceutical University, Tokyo, Japan
, Tatsunori Murata3 CRECON Medical Assessment Inc., Tokyo, Japan
, Toshihiko Taguchi4 Department of Orthopaedic Surgery, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan
, Alesia Sadosky5 Pfizer Inc., New York, NY, USACorrespondence[email protected]
, Nozomi Ebata6 Pfizer Japan, Inc., Tokyo, Japan
, Richard Willke5 Pfizer Inc., New York, NY, USA
, Koichi Fujii6 Pfizer Japan, Inc., Tokyo, Japan
, Jim Doherty5 Pfizer Inc., New York, NY, USA
& Makoto Kobayashi3 CRECON Medical Assessment Inc., Tokyo, Japan
show all
Pages 505-520
|
Published online: 07 Oct 2015
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.